Does RIBOCICLIB Cause Breast cancer metastatic? 1,450 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,450 reports of Breast cancer metastatic have been filed in association with RIBOCICLIB (KISQALI). This represents 5.2% of all adverse event reports for RIBOCICLIB.
1,450
Reports of Breast cancer metastatic with RIBOCICLIB
5.2%
of all RIBOCICLIB reports
488
Deaths
395
Hospitalizations
How Dangerous Is Breast cancer metastatic From RIBOCICLIB?
Of the 1,450 reports, 488 (33.7%) resulted in death, 395 (27.2%) required hospitalization, and 74 (5.1%) were considered life-threatening.
Is Breast cancer metastatic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 1,450 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Breast cancer metastatic?
LETROZOLE (1,540)
FULVESTRANT (1,165)
PALBOCICLIB (818)
TRASTUZUMAB (720)
CAPECITABINE (718)
PACLITAXEL (651)
EVEROLIMUS (634)
EXEMESTANE (591)
TAMOXIFEN (515)
DENOSUMAB (475)
Which RIBOCICLIB Alternatives Have Lower Breast cancer metastatic Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN